Index by author
Chew, Derek P.
- You have accessGP IIb/IIIa inhibitors in coronary artery disease management: What the latest trials tell usDerek P. Chew, MBBS and David J. Moliterno, MDCleveland Clinic Journal of Medicine December 2001, 68 (12) 1017-1023;
Recent trials addressed whether there are clinical differences among these drugs, whether their empiric use is justified in acute coronary syndromes, and whether they might allow for early invasive management in acute coronary syndromes.
Clough, John D.
- You have accessBioterrorism: An unintended boost to public health?John D. Clough, MDCleveland Clinic Journal of Medicine December 2001, 68 (12) 971;
If anything good comes of recent events, it might be rejuvination of America’s public health system, which has languished in recent years.
Kavuru, Mani
- You have accessOur new understanding of pulmonary alveolar proteinosis: What an internist needs to knowPeter Mazzone, MD, Mary Jane Thomassen, PhD and Mani Kavuru, MDCleveland Clinic Journal of Medicine December 2001, 68 (12) 977-993;
Recent advances point to a defect in granulocyte-macrophage colony stimulating factor (GM-CSF) as a cause of this disease. New treatments are under study.
Longworth, David L.
- You have accessBioterrorism: What practicing physicians can doJames C. Pile, MD and David L. Longworth, MDCleveland Clinic Journal of Medicine December 2001, 68 (12) 998-1000;
Given the specter of biological terrorism, the medical system has much to learn and much to do to prepare.
Mazzone, Peter
- You have accessOur new understanding of pulmonary alveolar proteinosis: What an internist needs to knowPeter Mazzone, MD, Mary Jane Thomassen, PhD and Mani Kavuru, MDCleveland Clinic Journal of Medicine December 2001, 68 (12) 977-993;
Recent advances point to a defect in granulocyte-macrophage colony stimulating factor (GM-CSF) as a cause of this disease. New treatments are under study.
Mette, Stephen A.
- You have accessWhen should central venous catheters be changed in the intensive care unit? Should there be a rigid time-based protocol for doing so?Stephen A. Mette, MDCleveland Clinic Journal of Medicine December 2001, 68 (12) 994-996;
The decision is made case by case rather than on a time-based protocol. Proactive strategies can reduce the risk of infection.
Moliterno, David J.
- You have accessGP IIb/IIIa inhibitors in coronary artery disease management: What the latest trials tell usDerek P. Chew, MBBS and David J. Moliterno, MDCleveland Clinic Journal of Medicine December 2001, 68 (12) 1017-1023;
Recent trials addressed whether there are clinical differences among these drugs, whether their empiric use is justified in acute coronary syndromes, and whether they might allow for early invasive management in acute coronary syndromes.
Noeller, Thomas P.
- You have accessBiological and chemical terrorism: Recognition and managementThomas P. Noeller, MDCleveland Clinic Journal of Medicine December 2001, 68 (12) 1001-1016;
Future terrorist attacks might involve a variety of chemical or biological agents, including nerve agents, blistering agents, hydrogen cyanide, ricin, anthrax, smallpox, plague, and botulinum toxin. Physicians are on the front line.
Pile, James C.
- You have accessBioterrorism: What practicing physicians can doJames C. Pile, MD and David L. Longworth, MDCleveland Clinic Journal of Medicine December 2001, 68 (12) 998-1000;
Given the specter of biological terrorism, the medical system has much to learn and much to do to prepare.
Rimmerman, Curtis M.
- You have accessA 62-year-old man with an abnormal electrocardiogramCurtis M. Rimmerman, MDCleveland Clinic Journal of Medicine December 2001, 68 (12) 975-976;
Questions and answers on the visible signs of diseases.